(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

AFLUXINA

This trademark appears in the official INPI history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

Registro de marca extintoType: CombinedOffice: Brazil

Quick snapshot

AFLUXINA

ST13

BR500000002801728

Class

5

Filing

002801728

Registration

002801728

Progress at the INPI

  1. Filing09/25/58
  2. Publication
  3. Examination
  4. Allowance
  5. Grant03/20/63
  6. Terminated10/17/23

The registration was granted on 03/20/1963 and later terminated. The mark is no longer protected.

Check whether this name is available

Latest action published by the INPI: 10/17/2023. We update with every new RPI gazette, published weekly.

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

INPI status

Registro de marca extinto

Case type

Application and registration

Recorded events

4

Latest update

10/17/2023

Trademark type

Combined

Nice classes

5

Filing date

09/25/1958

Registration date

03/20/1963

Expiration date

03/20/2023

Complete case details

Structured fields from the responsible authority and the official record.

Nature

De Produto

Responsible office

Brazil

Owner type

PESSOA JURÍDICA

Owner location

SC, BR

Holders and representatives

Holders

LABORATORIO FARMACEUTICO ELOFAR LIMITADA

Representatives

No representative data.

Technical classification

Nice Classes

Class 5

Vienna Codes

27.5.1

Goods and services

Class 5

Medicamentos que atuam sobre o aparelho respiratório

Publications

History of INPI decisions and trademark events.

4 publications found

IPAS161

Extinção de registro pela expiração do prazo de vigência

RPI 2754

10/17/2023

IPAS270

Deferimento da petição

Protocolo: 800130043249 (05/03/2013) Petição (tipo): Prorrogação de registro de marca e expedição de certificado no prazo ordinário (374.1) Titular: LABORATORIO FARMACEUTICO ELOFAR LIMITADA

RPI 2352

02/02/2016

990

CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.

PRORROGADO CONFORME RESOLUçãO 123 DE 06/01/2006, PUBLICADA NA RPI 1829, DE 24/01/2006.

RPI 1847

05/30/2006

990

CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.

INT. AGÕENCIA MODERNA

RPI 1163

03/16/1993

LABORATORIO FARMACEUTICO ELOFAR LIMITADA also protects technology and design at the INPI

1 patent application under the same owner.

Related trademarks

Other trademarks by LABORATORIO FARMACEUTICO ELOFAR LIMITADA

Continuous trademark protection

Get notified about every new filing that threatens AFLUXINA or your mark.

Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.